Playing

Investors look to biotech with COVID-19 vaccine on the horizon

Welcome to another podcast focusing on the topic du jour, indeed, the topic of the decade, even the topic of the century, biotechnology and the current pandemic. ETF Securities have created an exchange traded fund with the apt ASX code ‘Cure’ which provides individual investors and SMSFs easy and inexpensive access to the US biotech market.

The Inside Adviser

  • 22nd Jun 2020
    22nd Jun 2020

    Welcome to another podcast focusing on the topic du jour, indeed, the topic of the decade, even the topic of the century, biotechnology and the current pandemic. ETF Securities have created an exchange traded fund with the apt ASX code ‘Cure’ which provides individual investors and SMSFs easy and inexpensive access to the US biotech market.

    The Inside Adviser

  • Investors look to biotech with COVID-19 vaccine on the horizon

    More Episodes

    Private equity has been a consistent force in the private capital arena as both a source of capital for companies and returns for investorsThe Inside Network managing editor Tahn Sharpe sits with Nick Miller from Brisbane-based private equity purveyors Fortitude Investment Partners to discuss the rise of PE, its place in the private capital world and what investors should be wary of.

    The Inside Adviser

  • Investor Strategy News editor Lachlan Maddock talks to Cameron Brownjohn from Federation Asset Management about the firm’s latest buy and the growing opportunities for private equity investment in social and renewable energy infrastructure both in Australia and abroad. 

    The Inside Adviser

  • Lonsec chief executive Mike Wright sits down with The Inside Network managing editor Tahn Sharpe to discuss the firm’s recent acquisition by GDG, how managed accounts have radically altered the investment landscape and how the “new captains of capital” are wielding their influence.

    The Inside Adviser

  • Investor Strategy News editor Lachlan Maddock talks to listed infrastructure pioneer Nick Langley about emerging themes in the asset class and how to get exposure to the sweeping net zero transition.

    The Inside Adviser

  • Respected advice technology expert, Finura Group’s Peter Worn, grabs a coffee with The Inside Network managing editor Tahn Sharpe and chats about the systems and processes that form the backbone of the advice administration system; what works, what doesn’t, and where did I put my password?

    The Inside Adviser

  • The Inside Network managing editor Tahn Sharpe and Peloton Partners’ Rob Jones get together to talk about the vexed issue of pricing in financial advice; who’s getting it right, how should it be done and how to explain it to your clients. 

    The Inside Adviser

  • Investor Strategy News editor Lachlan Maddock chats to the inimitable Ian Fryer about all things superannuation, including the developing practices around super fund benchmarking and more. 

    The Inside Adviser

  • Popular